Showing results (81-90 of 282) with videos related to

Sort By:
Pageof 29
European Journal of Pharmacology|January 14, 1992
Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin)N E Rhaleb, N Rouissi, D Jukic, et al.
Oncology|January 1, 1975
In vitro cultivation of human tumor tissuesA Billiau, J J Cassiman, D Willems, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1985
Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemiasP S Mitrou, R Kuse, H Anger, et al.
Zeitschrift Fur Gastroenterologie|October 1, 1979
[Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers]W Arnold, G Hess, H H Dormeyer, et al.
Digestion|January 1, 1981
Follow-up of anti-HBc titers in healthy HBsAg carriers and patients with chronic inflammatory liver diseasesH H Dormeyer, W Arnold, H Schönborn, et al.
Gerontology|February 6, 1999
Clinical relevance of thiamine status amongst hospitalized elderly patientsT Pepersack, J Garbusinski, J Robberecht, et al.
Gastrointestinal Endoscopy|August 1, 1996
Colonoscopy without premedication versus barium enema: a comparison of patient discomfortV F Eckardt, G Kanzier, D Willems, et al.
Scandinavian Journal of Rheumatology|November 7, 2012
Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritisF Debaugnies, G Servais, V Badot, et al.
Bioorganic & Medicinal Chemistry|May 1, 1995
HIV protease inhibitor HOE/BAY 793, structure-activity relationships in a series of C2-symmetric diolsK H Budt, A Peyman, J Hansen, et al.
Dermatology (Basel, Switzerland)|April 6, 2011
Oral eosinophilic ulcer, an Epstein-Barr virus-associated CD30+ lymphoproliferation?M B Abdel-Naser, F Tsatsou, S Hippe, et al.
Pageof 29